Human SR-BI and SR-BII potentiate lipopolysaccharide-induced inflammation and acute liver and kidney injury in mice

Journal of Immunology

Volumn 196, Issue 7, 2016, Pages 3135-3147

  Baranova, Irina N ^a   Souza, Ana C P ^b   Bocharov, Alexander V ^a   Vishnyakova, Tatyana G ^a   Hu, Xuzhen ^b   Vaisman, Boris L ^c   Amar, Marcelo J ^c   Chen, Zhigang ^a   Kost, Yana ^a   Remaley, Alan T ^c   Patterson, Amy P ^a,c   Yuen, Peter S T ^b   Star, Robert A ^b   Eggerman, Thomas L ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLASS B SCAVENGER RECEPTOR BI; CLASS B SCAVENGER RECEPTOR BII; CRYOPYRIN; CXCL1 CHEMOKINE; GAMMA INTERFERON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HIGH DENSITY LIPOPROTEIN RECEPTOR; INFLAMMASOME; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CD36 ANTIGEN; CYTOKINE; LIPOPOLYSACCHARIDE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; SCARB2 PROTEIN, HUMAN; SCAVENGER RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HISTOLOGY; HUMAN; HUMAN CELL; INFLAMMATION; KIDNEY INJURY; LIVER INJURY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SEPSIS; TISSUE INJURY; ACUTE KIDNEY FAILURE; ANIMAL; ANTIBODY SPECIFICITY; BLOOD; CELL LINE; DISEASE MODEL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; LIVER DISEASE; MACROPHAGE; METABOLISM; PATHOLOGY; TRANSGENIC MOUSE;

ACUTE KIDNEY INJURY; ANIMALS; ANTIGENS, CD36; CELL LINE; CYTOKINES; DISEASE MODELS, ANIMAL; GENE EXPRESSION; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; LIVER DISEASES; LYSOSOME-ASSOCIATED MEMBRANE GLYCOPROTEINS; MACROPHAGES; MICE; MICE, TRANSGENIC; MITOGEN-ACTIVATED PROTEIN KINASES; NITRIC OXIDE SYNTHASE; ORGAN SPECIFICITY; RECEPTORS, SCAVENGER; RNA, MESSENGER;

EID: 84962574660     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501709     Document Type: Article

References (87)

1. Krieger, M. 2001. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J. Clin. Invest. 108:793-797.
2. Webb, N. R., P. M. Connell, G. A. Graf, E. J. Smart, W. J. De Villiers, F. C. De Beer, and D. R. Van Der Westhuyzen. 1998. SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J. Biol. Chem. 273:15241-15248.
3. Murao, K., V. Terpstra, S. R. Green, N. Kondratenko, D. Steinberg, and O. Quehenberger. 1997. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J. Biol. Chem. 272:17551-17557.
4. Baranova, I. N., T. G. Vishnyakova, A. V. Bocharov, R. Kurlander, Z. Chen, M. L. Kimelman, A. T. Remaley, G. Csako, F. Thomas, T. L. Eggerman, and A. P. Patterson. 2005. Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 280:8031-8040.
5. Cai, L., M. C. De Beer, F. C. De Beer, and D. R. Van Der Westhuyzen. 2005. Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake. J. Biol. Chem. 280:2954-2961.
6. Husemann, J., J. D. Loike, T. Kodama, and S. C. Silverstein. 2001. Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid. J. Neuroimmunol. 114:142-150.
7. Vishnyakova, T. G., R. Kurlander, A. V. Bocharov, I. N. Baranova, Z. Chen, M. S. Abu-Asab, M. Tsokos, D. Malide, F. Basso, A. Remaley, et al. 2006. CLA-1 and its splicing variant CLA-2 mediate bacterial adhesion and cytosolic bacterial invasion in mammalian cells. Proc. Natl. Acad. Sci. USA 103:16888-16893.
8. Philips, J. A., E. J. Rubin, and N. Perrimon. 2005. Drosophila RNAi screen reveals CD36 family member required for mycobacterial infection. Science 309:1251-1253.
9. Bird, D. A., K. L. Gillotte, S. Hörkkö, P. Friedman, E. A. Dennis, J. L. Witztum, and D. Steinberg. 1999. Receptors for oxidized low-density lipoprotein on elicited mouse peritoneal macrophages can recognize both the modified lipid moieties and the modified protein moieties: implications with respect to macrophage recognition of apoptotic cells. Proc. Natl. Acad. Sci. USA 96:6347-6352.
10. Zhang, W., P. G. Yancey, Y. R. Su, V. R. Babaev, Y. Zhang, S. Fazio, and M. F. Linton. 2003. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation 108:2258-2263.
11. Pei, Y., X. Chen, D. Aboutouk, M. T. Fuller, O. Dadoo, P. Yu, E. J. White, S. A. Igdoura, and B. L. Trigatti. 2013. SR-BI in bone marrow derived cells protects mice from diet induced coronary artery atherosclerosis and myocardial infarction. PLoS One 8:e72492.
12. Guo, L., Z. Song, M. Li, Q. Wu, D. Wang, H. Feng, P. Bernard, A. Daugherty, B. Huang, and X. A. Li. 2009. Scavenger receptor BI protects against septic death through its role in modulating inflammatory response. J. Biol. Chem. 284:19826-19834.
13. Leelahavanichkul, A., A. V. Bocharov, R. Kurlander, I. N. Baranova, T. G. Vishnyakova, A. C. Souza, X. Hu, K. Doi, B. Vaisman, M. Amar, et al. 2012. Class B scavenger receptor types I and II and CD36 targeting improves sepsis survival and acute outcomes in mice. J. Immunol. 188:2749-2758.
14. Baranova, I. N., T. G. Vishnyakova, A. V. Bocharov, A. Leelahavanichkul, R. Kurlander, Z. Chen, A. C. Souza, P. S. Yuen, R. A. Star, G. Csako, et al. 2012. Class B scavenger receptor types I and II and CD36 mediate bacterial recognition and proinflammatory signaling induced by Escherichia coli, lipopolysaccharide, and cytosolic chaperonin 60. J. Immunol. 188:1371-1380.
15. Guo, L., Z. Zheng, J. Ai, B. Huang, and X. A. Li. 2014. Hepatic scavenger receptor BI protects against polymicrobial-induced sepsis through promoting LPS clearance in mice. J. Biol. Chem. 289:14666-14673.
16. Catanese, M. T., H. Ansuini, R. Graziani, T. Huby, M. Moreau, J. K. Ball, G. Paonessa, C. M. Rice, R. Cortese, A. Vitelli, and A. Nicosia. 2010. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. J. Virol. 84:34-43.
17. Acton, S. L., P. E. Scherer, H. F. Lodish, and M. Krieger. 1994. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269:21003-21009.
18. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 271:518-520.
19. Azhar, S., and E. Reaven. 2002. Scavenger receptor class BI and selective cholesteryl ester uptake: partners in the regulation of steroidogenesis. Mol. Cell. Endocrinol. 195:1-26.
20. Brundert, M., A. Ewert, J. Heeren, B. Behrendt, R. Ramakrishnan, H. Greten, M. Merkel, and F. Rinninger. 2005. Scavenger receptor class B type I mediates the selective uptake of high-density lipoprotein-associated cholesteryl ester by the liver in mice. Arterioscler. Thromb. Vasc. Biol. 25:143-148.
21. Duncan, K. G., K. R. Bailey, J. P. Kane, and D. M. Schwartz. 2002. Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochem. Biophys. Res. Commun. 292:1017-1022.
22. Miquel, J. F., M. Moreno, L. Amigo, H. Molina, P. Mardones, I. I. Wistuba, and A. Rigotti. 2003. Expression and regulation of scavenger receptor class B type I (SR-BI) in gall bladder epithelium. Gut 52:1017-1024.
23. Zhang, Y., J. R. Da Silva, M. Reilly, J. T. Billheimer, G. H. Rothblat, and D. J. Rader. 2005. Hepatic expression of scavenger receptor class B type I (SRBI) is a positive regulator of macrophage reverse cholesterol transport in vivo. J. Clin. Invest. 115:2870-2874.
24. Chinetti, G., F. G. Gbaguidi, S. Griglio, Z. Mallat, M. Antonucci, P. Poulain, J. Chapman, J. C. Fruchart, A. Tedgui, J. Najib-Fruchart, and B. Staels. 2000. CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors. Circulation 101:2411-2417.
25. Cai, L., A. Ji, F. C. De Beer, L. R. Tannock, and D. R. Van Der Westhuyzen. 2008. SR-BI protects against endotoxemia in mice through its roles in glucocorticoid production and hepatic clearance. J. Clin. Invest. 118:364-375.
26. Li, X. A., L. Guo, R. Asmis, M. Nikolova-Karakashian, and E. J. Smart. 2006. Scavenger receptor BI prevents nitric oxide-induced cytotoxicity and endotoxininduced death. Circ. Res. 98:e60-e65.
27. Gowda, N. M., X. Wu, S. Kumar, M. Febbraio, and D. C. Gowda. 2013. CD36 contributes to malaria parasite-induced pro-inflammatory cytokine production and NK and T cell activation by dendritic cells. PLoS One 8:e77604.
28. Trigatti, B., H. Rayburn, M. Viñals, A. Braun, H. Miettinen, M. Penman, M. Hertz, M. Schrenzel, L. Amigo, A. Rigotti, and M. Krieger. 1999. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology. Proc. Natl. Acad. Sci. USA 96:9322-9327.
29. Yesilaltay, A., M. G. Morales, L. Amigo, S. Zanlungo, A. Rigotti, S. L. Karackattu, M. H. Donahee, K. F. Kozarsky, and M. Krieger. 2006. Effects of hepatic expression of the high-density lipoprotein receptor SR-BI on lipoprotein metabolism and female fertility. Endocrinology 147:1577-1588.
30. Feng, H., L. Guo, D. Wang, H. Gao, G. Hou, Z. Zheng, J. Ai, O. Foreman, A. Daugherty, and X. A. Li. 2011. Deficiency of scavenger receptor BI leads to impaired lymphocyte homeostasis and autoimmune disorders in mice. Arterioscler. Thromb. Vasc. Biol. 31:2543-2551.
31. Meurs, I., M. Hoekstra, E. J. Van Wanrooij, R. B. Hildebrand, J. Kuiper, F. Kuipers, M. R. Hardeman, T. J. Van Berkel, and M. Van Eck. 2005. HDL cholesterol levels are an important factor for determining the lifespan of erythrocytes. Exp. Hematol. 33:1309-1319.
32. Hoekstra, M., I. Meurs, M. Koenders, R. Out, R. B. Hildebrand, J. K. Kruijt, M. Van Eck, and T. J. Van Berkel. 2008. Absence of HDL cholesteryl ester uptake in mice via SR-BI impairs an adequate adrenal glucocorticoid-mediated stress response to fasting. J. Lipid Res. 49:738-745.
33. Simonet, W. S., N. Bucay, S. J. Lauer, and J. M. Taylor. 1993. A fardownstream hepatocyte-specific control region directs expression of the linked human apolipoprotein E and C-I genes in transgenic mice. J. Biol. Chem. 268:8221-8229.
34. Vaisman, B. L., H. G. Klein, M. Rouis, A. M. Bérard, M. R. Kindt, G. D. Talley, S. M. Meyn, R. F. Hoyt, Jr., S. M. Marcovina, J. J. Albers, et al. 1995. Overexpression of human lecithin cholesterol acyltransferase leads to hyperalphalipoproteinemia in transgenic mice. J. Biol. Chem. 270:12269-12275.
35. Eckhardt, E. R., L. Cai, B. Sun, N. R. Webb, and D. R. Van Der Westhuyzen. 2004. High density lipoprotein uptake by scavenger receptor SR-BII. J. Biol. Chem. 279:14372-14381.
36. Boaru, S. G., E. Borkham-Kamphorst, L. Tihaa, U. Haas, and R. Weiskirchen. 2012. Expression analysis of inflammasomes in experimental models of inflammatory and fibrotic liver disease. J. Inflamm. (Lond.) 9:49.
37. Kim, S. J., and S. M. Lee. 2013. NLRP3 inflammasome activation in Dgalactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1. Free Radic. Biol. Med. 65:997-1004.
38. Novogrodsky, A., A. Vanichkin, M. Patya, A. Gazit, N. Osherov, and A. Levitzki. 1994. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. Science 264:1319-1322.
39. Brandtzaeg, P., P. Kierulf, P. Gaustad, J. Dobloug, T. E. Mollnes, and K. Sirnes. 1988. Systemic meningococcal disease: a model infection to study acute endotoxinemia in man. Prog. Clin. Biol. Res. 272:263-271.
40. Guo, L., J. Ai, Z. Zheng, D. A. Howatt, A. Daugherty, B. Huang, and X. A. Li. 2013. High density lipoprotein protects against polymicrobe-induced sepsis in mice. J. Biol. Chem. 288:17947-17953.
41. Bultinck, J., P. Sips, L. Vakaet, P. Brouckaert, and A. Cauwels. 2006. Systemic NO production during (septic) shock depends on parenchymal and not on hematopoietic cells: in vivo iNOS expression pattern in (septic) shock. FASEB J. 20:2363-2365.
42. Vodovotz, Y., S. Liu, C. McCloskey, R. Shapiro, A. Green, and T. R. Billiar. 2001. The hepatocyte as a microbial product-responsive cell. J. Endotoxin Res. 7:365-373.
43. Chassin, C., J. M. Goujon, S. Darche, L. Du Merle, M. Bens, F. Cluzeaud, C. Werts, E. Ogier-Denis, C. Le Bouguénec, D. Buzoni-Gatel, and A. Vandewalle. 2006. Renal collecting duct epithelial cells react to pyelonephritis-associated Escherichia coli by activating distinct TLR4-dependent and -independent inflammatory pathways. J. Immunol. 177:4773-4784.
44. Rietschel, E. T., T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zähringer, U. Seydel, F. Di Padova, et al. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8:217-225.
45. Li, X., D. Klintman, Q. Liu, T. Sato, B. Jeppsson, and H. Thorlacius. 2004. Critical role of CXC chemokines in endotoxemic liver injury in mice. J. Leukoc. Biol. 75:443-452.
46. Wang, W., S. Bansal, S. Falk, D. Ljubanovic, and R. Schrier. 2009. Ghrelin protects mice against endotoxemia-induced acute kidney injury. Am. J. Physiol. Renal Physiol. 297:F1032-F1037.
47. Zahedi, K., S. Barone, D. L. Kramer, H. Amlal, L. Alhonen, J. Jänne, C. W. Porter, and M. Soleimani. 2010. The role of spermidine/spermine N1-acetyltransferase in endotoxin-induced acute kidney injury. Am. J. Physiol. Cell Physiol. 299:C164-C174.
48. Wu, H., G. Chen, K. R. Wyburn, J. Yin, P. Bertolino, J. M. Eris, S. I. Alexander, A. F. Sharland, and S. J. Chadban. 2007. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117:2847-2859.
49. Cunningham, P. N., Y. Wang, R. Guo, G. He, and R. J. Quigg. 2004. Role of Tolllike receptor 4 in endotoxin-induced acute renal failure. J. Immunol. 172:2629-2635.
50. Campbell, M. T., K. L. Hile, H. Zhang, H. Asanuma, B. A. Vanderbrink, R. R. Rink, and K. K. Meldrum. 2011. Toll-like receptor 4: a novel signaling pathway during renal fibrogenesis. J. Surg. Res. 168:e61-e69.
51. Chiba-Falek, O., M. Nichols, S. Suchindran, J. Guyton, G. S. Ginsburg, E. Barrett-Connor, and J. J. McCarthy. 2010. Impact of gene variants on sexspecific regulation of human Scavenger receptor class B type 1 (SR-BI) expression in liver and association with lipid levels in a population-based study. BMC Med. Genet. 11:9.
52. Akpovi, C. D., S. R. Yoon, M. L. Vitale, and R. M. Pelletier. 2006. The predominance of one of the SR-BI isoforms is associated with increased esterified cholesterol levels not apoptosis in mink testis. J. Lipid Res. 47:2233-2247.
53. Cai, S. F., R. J. Kirby, P. N. Howles, and D. Y. Hui. 2001. Differentiationdependent expression and localization of the class B type I scavenger receptor in intestine. J. Lipid Res. 42:902-909.
54. Tsun, J. G., S. Yung, M. K. Chau, S. W. Shiu, T. M. Chan, and K. C. Tan. 2014. Cellular cholesterol transport proteins in diabetic nephropathy. PLoS One 9:e105787.
55. Van Kooten, C., M. R. Daha, and L. A. Van Es. 1999. Tubular epithelial cells: A critical cell type in the regulation of renal inflammatory processes. Exp. Nephrol. 7:429-437.
56. Tang, S. C., J. C. Leung, L. Y. Chan, A. W. Tsang, and K. N. Lai. 2006. Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist. J. Am. Soc. Nephrol. 17:1633-1643.
57. Kalakeche, R., T. Hato, G. Rhodes, K. W. Dunn, T. M. El-Achkar, Z. Plotkin, R. M. Sandoval, and P. C. Dagher. 2011. Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment. J. Am. Soc. Nephrol. 22:1505-1516.
58. Van Kooten, C., and M. R. Daha. 2001. Cytokine cross-talk between tubular epithelial cells and interstitial immunocompetent cells. Curr. Opin. Nephrol. Hypertens. 10:55-59.
59. Schmouder, R. L., R. M. Strieter, R. C. Wiggins, S. W. Chensue, and S. L. Kunkel. 1992. In vitro and in vivo interleukin-8 production in human renal cortical epithelia. Kidney Int. 41:191-198.
60. Franquesa, M., M. Riera, I. Herrero-Fresneda, A. Sola, G. Hotter, N. Lloberas, J. M. Cruzado, J. Torras, and J. M. Grinyó. 2009. Tubular epithelial cells transfected with hHGF counteracts monocyte chemotactic protein-1 upregulation after hypoxia/reoxygenation insult. Transplant. Proc. 41:2069-2072.
61. Ganz, M., T. Csak, B. Nath, and G. Szabo. 2011. Lipopolysaccharide induces and activates the Nalp3 inflammasome in the liver. World J. Gastroenterol. 17:4772-4778.
62. Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-241.
63. Tsutsui, H., M. Imamura, J. Fujimoto, and K. Nakanishi. 2010. The TLR4/TRIFmediated activation of NLRP3 inflammasome underlies endotoxin-induced liver injury in mice. Gastroenterol. Res. Pract. 2010:641865.
64. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proILbeta. Mol. Cell 10:417-426.
65. Tunçtan, B., O. Uludag, S. Altug, and N. Abacioglu. 1998. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. Pharmacol. Res. 38:405-411.
66. Numata, M., S. Suzuki, N. Miyazawa, A. Miyashita, Y. Nagashima, S. Inoue, T. Kaneko, and T. Okubo. 1998. Inhibition of inducible nitric oxide synthase prevents LPS-induced acute lung injury in dogs. J. Immunol. 160:3031-3037.
67. Ahmad, N., L. C. Chen, M. A. Gordon, J. D. Laskin, and D. L. Laskin. 2002. Regulation of cyclooxygenase-2 by nitric oxide in activated hepatic macrophages during acute endotoxemia. J. Leukoc. Biol. 71:1005-1011.
68. Wong, J. M., and T. R. Billiar. 1995. Regulation and function of inducible nitric oxide synthase during sepsis and acute inflammation. Adv. Pharmacol. 34:155-170.
69. Bogdan, C. 2001. Nitric oxide and the immune response. Nat. Immunol. 2:907-916.
70. Temel, R. E., B. Trigatti, R. B. De Mattos, S. Azhar, M. Krieger, and D. L. Williams. 1997. Scavenger receptor class B, type I (SR-BI) is the major route for the delivery of high density lipoprotein cholesterol to the steroidogenic pathway in cultured mouse adrenocortical cells. Proc. Natl. Acad. Sci. USA 94:13600-13605.
71. Hoekstra, M., D. Ye, R. B. Hildebrand, Y. Zhao, B. Lammers, M. Stitzinger, J. Kuiper, T. J. Van Berkel, and M. Van Eck. 2009. Scavenger receptor class B type I-mediated uptake of serum cholesterol is essential for optimal adrenal glucocorticoid production. J. Lipid Res. 50:1039-1046.
72. Gilibert, S., L. Galle-Treger, M. Moreau, F. Saint-Charles, S. Costa, R. Ballaire, P. Couvert, A. Carrié, P. Lesnik, and T. Huby. 2014. Adrenocortical scavenger receptor class B type I deficiency exacerbates endotoxic shock and precipitates sepsis-induced mortality in mice. J. Immunol. 193:817-826.
73. Kim, S. H., J. Kim, and R. P. Sharma. 2004. Inhibition of p38 and ERK MAP kinases blocks endotoxin-induced nitric oxide production and differentially modulates cytokine expression. Pharmacol. Res. 49:433-439.
74. Lee, S. J., and K. T. Lim. 2009. Inhibitory effect of ZPDC glycoprotein on the expression of inflammation-related cytokines through p38 MAP kinase and JNK in lipopolysaccharide-stimulated RAW 264.7 cells. Inflamm. Res. 58:184-191.
75. Ikemoto, M., H. Arai, D. Feng, K. Tanaka, J. Aoki, N. Dohmae, K. Takio, H. Adachi, M. Tsujimoto, and K. Inoue. 2000. Identification of a PDZ-domaincontaining protein that interacts with the scavenger receptor class B type I. Proc. Natl. Acad. Sci. USA 97:6538-6543.
76. Mineo, C., I. S. Yuhanna, M. J. Quon, and P. W. Shaul. 2003. High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases. J. Biol. Chem. 278:9142-9149.
77. Zhu, W., S. Saddar, D. Seetharam, K. L. Chambliss, C. Longoria, D. L. Silver, I. S. Yuhanna, P. W. Shaul, and C. Mineo. 2008. The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity. Circ. Res. 102:480-487.
78. Mulcahy, J. V., D. R. Riddell, and J. S. Owen. 2004. Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux. Biochem. J. 377:741-747.
79. Fukuda, M., H. Yokoyama, T. Mizukami, H. Ohgo, Y. Okamura, Y. Kamegaya, Y. Horie, S. Kato, and H. Ishii. 2004. Kupffer cell depletion attenuates superoxide anion release into the hepatic sinusoids after lipopolysaccharide treatment. J. Gastroenterol. Hepatol. 19:1155-1162.
80. El Kasmi, K. C., A. L. Anderson, M. W. Devereaux, S. A. Fillon, J. K. Harris, M. A. Lovell, M. J. Finegold, and R. J. Sokol. 2012. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology 55:1518-1528.
81. Juskewitch, J. E., J. L. Platt, B. E. Knudsen, K. L. Knutson, G. J. Brunn, and J. P. Grande. 2012. Disparate roles of marrow- and parenchymal cell-derived TLR4 signaling in murine LPS-induced systemic inflammation. Sci. Rep. 2:918.
82. Rogers, N. M., D. A. Ferenbach, J. S. Isenberg, A. W. Thomson, and J. Hughes. 2014. Dendritic cells and macrophages in the kidney: a spectrum of good and evil. Nat. Rev. Nephrol. 10:625-643.
83. Liu, S., D. J. Gallo, A. M. Green, D. L. Williams, X. Gong, R. A. Shapiro, A. A. Gambotto, E. L. Humphris, Y. Vodovotz, and T. R. Billiar. 2002. Role of toll-like receptors in changes in gene expression and NF-kappa B activation in mouse hepatocytes stimulated with lipopolysaccharide. Infect. Immun. 70:3433-3442.
84. Wang, Y., G. K. Rangan, B. Goodwin, Y. C. Tay, and D. C. Harris. 2000. Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-kappaB dependent. Kidney Int. 57:2011-2022.
85. Tiwari, M. M., K. J. Messer, and P. R. Mayeux. 2006. Inducible nitric oxide synthase and apoptosis in murine proximal tubule epithelial cells. Toxicol. Sci. 91:493-500.
86. Scott, M. J., S. Liu, R. A. Shapiro, Y. Vodovotz, and T. R. Billiar. 2009. Endotoxin uptake in mouse liver is blocked by endotoxin pretreatment through a suppressor of cytokine signaling-1-dependent mechanism. Hepatology 49:1695-1708.
87. Graf, G. A., K. L. Roswell, and E. J. Smart. 2001. 17beta-Estradiol promotes the up-regulation of SR-BII in HepG2 cells and in rat livers. J. Lipid Res. 42:1444-1449.